Anti-thrombosis benefit unclear in cancer patients with catheters NEW YORK (Reuters Health) - Pooled data from randomized trials does not clearly demonstrate a significant advantage for thromboprophylaxis in cancer patients with central venous catheters, according to North American and Italian researchers....
Comprehensive thrombosis guidelines published Hamilton, ON - New recommendations on antithrombotic and thrombolytic therapy from the American College of Chest Physicians have been published as a supplement to the June issue of Chest [1].Guidelines panel chair Dr Jack Hirsh (Henderson...
Letting the genome out of the bottle: Unraveling the genetics of heart disease London, UK - At the AHA Scientific Sessions in Orlando last November, deCODE Genetics offered its test for 9p21a variant that is recognized to be the strongest genetic predictor of early MI discovered to date [1,2,3]retailing at around $200,...
RECORD1, 2 and 3 rivaroxaban trials published Hamilton, ON - Three trials of the new oral anticoagulant rivaroxaban, showing impressive results in the prevention of venous thromboembolism (VTE) in patients undergoing orthopedic surgery, were published last week.A pooled analysis from...
New Reductions in CMS Payments Shine Spotlight on Profession can save livesand moneyby preventing DVT, infections and other illnesses targeted under new rule Cornelia Kean The proposal of the Centers for Medicare & Medicaid Services (CMS) to name nine new illnesses and conditions...
Novel oral anticoagulant reduces VTE risk in arthroplasty patients MedWire News: The investigational oral factor (F)Xa inhibitor rivaroxaban is more effective than the low molecular weight heparin (LMWH) enoxaparin at preventing venous thromboembolism (VTE) in patients recovering from joint replacement...
Characteristics of the Amiodarone-Warfarin Interaction During Long-term Follow-Up _ Characteristics of the Amiodarone-Warfarin Interaction During Long-term Follow-Up.
Extended FXa inhibitor VTE prophylaxis beats short-term enoxaparin MedWire News: Study findings show that extended treatment with the oral factor (F)Xa inhibitor rivaroxaban offers better protection against venous thromboembolism (VTE) than short-term enoxaparin therapy in patients undergoing total hip...
Comprehensive Thrombosis Guidelines Published New recommendations on antithrombotic and thrombolytic therapy from the American College of Chest Physicians (ACCP) have been published as a supplement to the June issue of Chest [1].Guidelines panel chair Dr Jack Hirsh (Henderson...
FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents WOODCLIFF LAKE, N.J., June 30 /PRNewswire/ -- Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., announced today that the Food and Drug Administration (FDA) has approved ACIPHEX (rabeprazole sodium)...
Clinical Data Secures EU Patent for MDR1 €' A Key Multi-Drug Resistance Gene Clinical Data, Inc.has announced that the European Patent Office has granted Patent No.1232260 to Bernried, Germany-based Epidauros Biotechnologie AG, a wholly-owned subsidiary of Clinical Data, relating to the use of a genetic variant,...
Clinical Data Secures EU Patent for MDR1 - A Key Multi-Drug Resistance Gene Clinical Data, Inc.has announced that the European Patent Office has granted Patent No.1232260 to Bernried, Germany-based Epidauros Biotechnologie AG, a wholly-owned subsidiary of Clinical Data, relating to the use of a genetic variant,...
New England Journal of Medicine and the Lancet Publish Results from Landmark Rivaroxaban Studies Data from three Phase III studies show rivaroxaban superior to standard of care in preventing venous blood clots after elective total hip and knee replacement surgeries << - Head-to-Head trials involving over 9,000 patients...
New Thromboembolic Guidelines May Spark Controversy NORTHBROOK, Ill., June 26 -- Most of the recommendations in the eighth edition of antithrombotic guidelines from the American College of Chest Physicians are only incrementally changed, but several are likely to be controversial, according...
Potential Interaction Between Warfarin and High Dietary Protein Intake _ Potential Interaction Between Warfarin and High Dietary Protein Intake.
Evidence piles up in support of Bayer/J&J's rivaroxaban Impressive data from three trials have been published which once again demonstrate the superiority of Bayer/Johnson & Johnsons new oral anticoagulant rivaroxaban over Sanofi-Aventis Lovenox.First of all, The Lancet published data...
New Anti-Clotting Pill Works Well in Trials WEDNESDAY, June 25 (HealthDay News) -- A new anti-clotting drug that could be one of the long-sought alternatives to commonly used blood thinners has performed well in hip and knee replacement patients, physicians report.The drug,...
Watchman Left Atrial Appendage System: Clinical Trial of Non-surgical Intervention for Patients with Atrial Fi Source: Cedars-Sinai Medical Center Libraries Medical News Keywords WATCHMAN LEFT ATRIAL APPENDAGE SYSTEM, ATRIAL FIBRILLATION, LEFT ATRIAL APPENDAGE Contact Information Available for logged-in reporters only Description Fixing Hearts from...
Coagulation - Reports summarize coagulation research from A. Alwitry and co-authors According to a study from Nottingham, the United Kingdom, ' To identify the practices of ophthalmologists when undertaking surgery on patients concurrently using or acetylsalicylic acid (aspirin).A questionnaire was designed to examine...
Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women /PRNewswire/ -- New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.Published as a supplement in the...
New evidence-based blood clot guidelines for pregnant women New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.Published as a supplement in the June issue of...
Warfarin Drug Interactions: The Role of Genetics Genetic variations can impact warfarin metabolism.Horn and Hansten are both professors of pharmacy at the University of Washington School of Pharmacy.
For an electronic version of this article, including references if any, visit...
Norwegian Institute of Public Health - New method identifies rat poison in humans Researchers at the (NIPH) have developed a method to identify bromadiolone poisoning in humans.Bromadiolone is a rat poison that can be purchased freely in shops.
A number of cases have been reported internationally where people have...
Lingual haematoma: a rare complication of usual warfarin dose Department of Emergency Medicine, Selcuk University Meram Medical School, Konya, Turkey Correspondence to:Dr F Acar, Kalenderhane M Hzrbey S Karatay Site A No: 1/32, 42050 Karatay-Konya, Turkey; drfacar@selcuk.edu.tr The first 150 words of...
Interruption of anticoagulation not linked to increased adverse events in AF NEW YORK (Reuters Health) - The 3-month cumulative incidence of thromboembolism and bleeding is 'not significantly influenced' by a temporary interruption in anticoagulation in patients in nonvalvular atrial fibrillation (AF), according to a...
